Phase 4 Acute Coronary Syndromes Clinical Trials
3 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–3 of 3 trials
Recruiting
Phase 4
Impact of Atorvastatin Versus Rosuvastatin on 25 Hydroxy Vitamin D Levels in Patients With Acute Coronary Syndrome
Acute Coronary Syndromes
King Edward Medical University152 enrolled1 locationNCT06765265
Recruiting
Phase 4
Biomarker-guided Management Following a Heart Attack
Secondary prevention post-acute coronary syndromesCardiovascular Disease
Professor Rob Doughty1,028 enrolled1 locationACTRN12619001445167
Completed
Phase 4
THE IMPACT OF THREE DIFFERENT GLYCOPROTEIN PLATELET RECEPTOR IIb/IIIa ANTAGONISTS ON GLYCOPROTEIN IIb/IIIa PLATELET RECEPTOR INHIBITION AND CLINICAL ENDPOINTS IN PATIENTS WITH ACUTE CORONARY SYNDROMES
Assessing patients presenting with acute coronary syndromes, aiming to reduce adverse cardiac outcomes.
A/Professor Craig Juergens210 enrolled1 locationACTRN12607000328471